First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met
- Majem, M.
- Sullivan, I.
- Viteri, S.
- López-Vivanco, G.
- Cobo, M.
- Sánchez, J.M.
- García-González, J.
- Garde, J.
- Sampayo, M.
- Martrat, G.
- Malfettone, A.
- Karachaliou, N.
- Molina-Vila, M.A.
- Rosell, R.
ISSN: 1879-0852, 0959-8049
Year of publication: 2021
Volume: 159
Pages: 174-181
Type: Article